MedTrace Logo

Effects of an Omega-3 Fatty Acid-based Supplement on Healthy Ageing

NCT06150261 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-01-14

No results posted yet for this study

Summary

The goal of this randomised, double-blind placebo controlled trial is to explore tolerability and the effects of a new omega-3 fatty acid-based supplement on biological and clinical aspects relevant for healthy ageing.

Participants will be asked to take a supplement or a placebo for 6 months, and to attend the clinic a total of 3 times and to perform or submit the following:

* Physical examination
* Muscle function tests
* Cognitive testing
* Questionnaire completion
* Biological samples, including blood, saliva and faeces.

Researchers will compare the results from the group taking the supplement to the results of the group taking a placebo to see if the supplement has an effect on biological and clinical aspects associated with healthy ageing.

Conditions

  • Healthy Aging
  • Ageing Well

Interventions

DIETARY_SUPPLEMENT

AvailOm

5 capsules taken once daily with main meal

DIETARY_SUPPLEMENT

Placebo

5 capsules taken once daily with main meal

Sponsors & Collaborators

  • Evonik Industries AG

    collaborator UNKNOWN

  • Helse Stavanger HF

    lead OTHER_GOV

Principal Investigators

  • Dag Aarsland, PhD · Helse Stavanger HF

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-08
Primary Completion
2025-08-31
Completion
2025-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06150261 on ClinicalTrials.gov